Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.

•Some individuals have stronger immune responses against all serotypes in PCV.•Increasing time since vaccination was associated decreasing antibody levels.•Older participants tended to have higher antibody levels than younger participants.